Genmab — Juni 2017

[nik_hs1990]

ja det ser forrygende ud.

[StockBull]

NBI rykker held godt +1,7%

[StockBull]

Helt

[E_L]

Johnson & Johnson does not have its own PD-1 inhibitor , or does it? http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=711569&isEPVantage=yes

[Solsen]

They have one on the move...

[Solsen]

ClinicalTrials.gov

(clinicaltrials.gov)

[Solsen]

NCI Drug Dictionary

Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes links to find associated clinical trials.

(www.cancer.gov)

[Solsen]

http://files.shareholder.com/downloads/JNJ/4524526832x0x943361/95AFD3A4-424F-478E-9914-6CBAF56D2D06/Peter_Lebowitz_Slides.pdf Last but not least

[E_L]

Thank you. I guess that means JnJ could offer a competitive combo package in the future if their PD1
is successful

[Solsen]

Once more I will tell the world that anti-cd38 works better than anti-pd1 in solid cancer as mono but has superior effect in combo with anti-pd1. Think about that

[E_L]

yes. yes, that is my hope also. Combo to start with, Dara for maintenance.

[E_L]

Keep telling the world

[stckchild]

Tør man mon håbe på endnu en god Gen dag imorgen

[Solsen]

You can count on me....

[digafarm]

Med ASCO rundt om hjørnet og en stigning i dag under høj volumen,
så tegner det da fint

[digafarm]

Så ligger der også lige en godkendelse og glimter et lille stykke vej forude

[Bulder]

Hvad begrunder du det med, Solsen, at anti-cd38 skulle virke bedre end anti pd1 i solide kræftformer?

[Solsen]

Hvis du har citis rapport fra i dag kan du se et diagram vise det. De skriver det tillige og vi har tidligere set det. EL har ligesom jeg et optimistisk håb om at dara kan blive et vedligeholdelses "drug" til at stoppe eller forsinke cancer.

[Bulder]

du kunne vel ikke lokkes til at uploade det diagram?

[Solsen]

Citi har tre forskellige referencer på at anti-cd38 har effekt i solide cancer. Det ene afsnit slutter med, citat: